You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 10, March 12, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (69)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Plasma Homocysteine and Risk for Congestive Heart Failure in Adults Without Prior Myocardial Infarction

Ramachandran S. Vasan, MD; Alexa Beiser, PhD; Ralph B. D'Agostino, PhD; Daniel Levy, MD; Jacob Selhub, PhD; Paul F. Jacques, ScD; Irwin H. Rosenberg, MD; Peter W. F. Wilson, MD

JAMA. 2003;289:1251-1257.

Context  Elevated plasma homocysteine levels are associated with increased risk of vascular disease. It is unclear whether elevated homocysteine levels are a risk factor for congestive heart failure (CHF).

Objective  To study prospectively the association between nonfasting plasma homocysteine and incidence of CHF.

Design, Setting, and Participants  Community-based prospective cohort study of 2491 adults (mean age 72 years, 1547 women) who participated in the Framingham Heart Study during the 1979-1982 and 1986-1990 examinations and were free of CHF or prior myocardial infarction (recognized or unrecognized) at baseline.

Main Outcome Measure  Incidence of a first episode of CHF during an 8-year follow-up period.

Results  During follow-up, 156 subjects (88 women) developed CHF. In multivariable analyses controlling for established risk factors for CHF including the occurrence of myocardial infarction (recognized or unrecognized) during follow-up, plasma homocysteine levels higher than the sex-specific median value were associated with an adjusted hazards ratio for heart failure of 1.93 in women (95% confidence interval, 1.19-3.14) and 1.84 in men (95% confidence interval, 1.06-3.17). The relation of plasma homocysteine levels to CHF risk was more continuous in women than in men. In analyses restricted to participants without any manifestation of coronary heart disease at baseline, the association of plasma homocysteine levels with risk of CHF was maintained in men and women.

Conclusions  An increased plasma homocysteine level independently predicts risk of the development of CHF in adults without prior myocardial infarction. Additional investigations are warranted to confirm these findings.


Author Affiliations: National Heart, Lung, and Blood Institute's Framingham Heart Study (Drs Vasan, Beiser, D' Agostino, Levy, and Wilson), Framingham, Mass; Cardiology Section (Dr Vasan), Endocrinology Section (Dr Wilson), Preventive Medicine and Epidemiology (Drs Vasan, Levy, and Wilson), Department of Medicine, Boston University School of Medicine, and Department of Biostatistics, Boston University School of Public Health (Dr Beiser); and Department of Mathematics (Dr D'Agostino), Boston University, Boston, Mass; the Divisions of Cardiology and Clinical Epidemiology, Beth Israel Deaconess Medical Center (Dr Levy), Boston, Mass; and the National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Levy); the Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging (Drs Selhub, Jacques, and Rosenberg) at Tufts University, Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Asymmetric Dimethylarginine Reference Intervals Determined with Liquid Chromatography-Tandem Mass Spectrometry: Results from the Framingham Offspring Cohort
Schwedhelm et al.
Clin. Chem. 2009;55:1539-1545.
ABSTRACT | FULL TEXT  

Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1
Moshal et al.
Am. J. Physiol. Heart Circ. Physiol. 2009;296:H887-H892.
ABSTRACT | FULL TEXT  

C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Wilson et al.
Circ Cardiovasc Qual Outcomes 2008;1:92-97.
ABSTRACT | FULL TEXT  

Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation
Shimano et al.
Europace 2008;10:961-966.
ABSTRACT | FULL TEXT  

Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia
Moshal et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;295:H890-H897.
ABSTRACT | FULL TEXT  

Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group
Schocken et al.
Circulation 2008;117:2544-2565.
ABSTRACT | FULL TEXT  

Effect of Folic Acid and Vitamins B6 and B12 on Microcirculatory Vasoreactivity in Patients With Hyperhomocysteinemia
Abularrage et al.
VASC ENDOVASCULAR SURG 2007;41:339-345.
ABSTRACT  

Mesna as a Nonvitamin Intervention to Lower Plasma Total Homocysteine Concentration: Implications for Assessment of the Homocysteine Theory of Atherosclerosis
Urquhart et al.
J Clin Pharmacol 2007;47:991-997.
ABSTRACT | FULL TEXT  

Associations of Plasma Natriuretic Peptide, Adrenomedullin, and Homocysteine Levels With Alterations in Arterial Stiffness: The Framingham Heart Study
Levy et al.
Circulation 2007;115:3079-3085.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemia and Myocardial Expression of Brain Natriuretic Peptide in Rats
Herrmann et al.
Clin. Chem. 2007;53:773-780.
ABSTRACT | FULL TEXT  

Elevated Homocysteine Is Associated With Reduced Regional Left Ventricular Function: The Multi-Ethnic Study of Atherosclerosis
Nasir et al.
Circulation 2007;115:180-187.
ABSTRACT | FULL TEXT  

Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure
von Haehling et al.
Cardiovasc Res 2007;73:298-309.
ABSTRACT | FULL TEXT  

Plasma B vitamins and their relation to the severity of chronic heart failure
Herrmann et al.
Am. J. Clin. Nutr. 2007;85:117-123.
ABSTRACT | FULL TEXT  

A review of homocysteine and heart failure
Herrmann et al.
Eur J Heart Fail 2006;8:571-576.
ABSTRACT | FULL TEXT  

The Many Facets of Hyperhomocysteinemia: Studies from the Framingham Cohorts
Selhub
J. Nutr. 2006;136:1726S-1730S.
ABSTRACT | FULL TEXT  

Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
Hillege et al.
Circulation 2006;113:671-678.
ABSTRACT | FULL TEXT  

Association of Plasma Homocysteine With Coronary Artery Calcification in Different Categories of Coronary Heart Disease Risk
Kullo et al.
Mayo Clin Proc. 2006;81:177-182.
ABSTRACT | FULL TEXT  

Serum Homocysteine Concentration of US Adults Associated with Fortified Cereal Consumption
Song et al.
J. Am. Coll. Nutr. 2005;24:503-509.
ABSTRACT | FULL TEXT  

Total Plasma Homocysteine and Arteriosclerotic Outcomes in Type 2 Diabetes with Nephropathy
Friedman et al.
J. Am. Soc. Nephrol. 2005;16:3397-3402.
ABSTRACT | FULL TEXT  

The Effect of Folate Fortification of Cereal-Grain Products on Blood Folate Status, Dietary Folate Intake, and Dietary Folate Sources among Adult Non-Supplement Users in the United States
Dietrich et al.
J. Am. Coll. Nutr. 2005;24:266-274.
ABSTRACT | FULL TEXT  

Relationship of Plasma Homocysteine with the Severity of Chronic Heart Failure
Herrmann et al.
Clin. Chem. 2005;51:1512-1515.
FULL TEXT  

Protective role of mast cells in homocysteine-induced cardiac remodeling
Joseph et al.
Am. J. Physiol. Heart Circ. Physiol. 2005;288:H2541-H2545.
ABSTRACT | FULL TEXT  

Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults
Sarnak et al.
ANN INTERN MED 2005;142:497-505.
ABSTRACT | FULL TEXT  

S-Adenosylmethionine and 5-Methyltetrahydrofolate Are Associated With Endothelial Function After Controlling for Confounding by Homocysteine: The Hoorn Study
Spijkerman et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:778-784.
ABSTRACT | FULL TEXT  

Hyperhomocysteinemia Is Inversely Related With Left Ventricular Ejection Fraction and Predicts Cardiovascular Mortality in High-Risk Coronary Artery Disease Hypertensives
Cesari et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:115-121.
ABSTRACT | FULL TEXT  

Fasting Plasma Total Homocysteine Levels and Mortality and Allograft Loss in Kidney Transplant Recipients: A Prospective Study
Winkelmayer et al.
J. Am. Soc. Nephrol. 2005;16:255-260.
ABSTRACT | FULL TEXT  

Acute negative inotropic effects of homocysteine are mediated via the endothelium
Kennedy et al.
Am. J. Physiol. Heart Circ. Physiol. 2004;287:H812-H817.
ABSTRACT | FULL TEXT  

Plasma homocysteine levels and risk of Alzheimer disease
Luchsinger et al.
Neurology 2004;62:1972-1976.
ABSTRACT | FULL TEXT  

Communicating Cardiovascular Disease Risk Due to Elevated Homocysteine Levels: Using the EPPM to Develop Print Materials
McKay et al.
Health Educ Behav 2004;31:355-371.
ABSTRACT  

Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study
Sundstrom et al.
Eur Heart J 2004;25:523-530.
ABSTRACT | FULL TEXT  

Homocysteine Elevation Linked with HF risk
Journal Watch Cardiology 2003;2003:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.